2025-2026 Session
Change SessionH.266
An act relating to the 340B prescription drug pricing program
Rep. Alyssa Black
Senate Committee on Health and Welfare
3/20/2025 - Read 1st time & referred to Committee on Health and Welfare
- Sponsor(s)
- Location
- Senate Committee on Health and Welfare
- Last Recorded Action
- Senate 3/20/2025 - Read 1st time & referred to Committee on Health and Welfare
Bill/Resolution Text
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to the 340B prescription drug pricing program
Detailed Status
Regular Session 2025-2026
| Body | Date | Journal | Calendar | Location | Full Status |
|---|
An act relating to the 340B prescription drug pricing program
Roll Call History
Regular Session 2025-2026
| Body | Date | Journal | Location | Full Status |
|---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to the 340B prescription drug pricing program
Committee Meetings
Regular Session 2025-2026
| Meeting Date | Committee |
|---|
An act relating to the 340B prescription drug pricing program
Meeting Full List
Regular Session 2025-2026
Wednesday, February 26, 2025
- Committee(s):
- House Committee on Health Care
- 1:00 PM
-
H.266 - An act relating to the 340B prescription drug pricing program
Walk-through
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
- 1:15 PM
-
H.266 - An act relating to the 340B prescription drug pricing program
Colleen Meiman, National Policy Advisor, State Associations of Community Health Centers
Georgia Maheras, Senior Vice President of Policy and Strategy, Bi-State Primary Care Association
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Kelly Ryan, Deputy Vice President of State Policy, Pharmaceutical Research and Manufacturers of America (PhRMA)
- 3:45 PM
-
H.266 - An act relating to the 340B prescription drug pricing program
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross Blue Shield of Vermont
Thomas Weigel, Vice President and Chief Medical Officer, Blue Cross Blue Shield of Vermont
Thursday, February 27, 2025
- Committee(s):
- House Committee on Health Care
- 9:45 AM
-
H.266 - An act relating to the 340B prescription drug pricing program
Jordan Estey, V.P. Government Affairs, MVP Health Care
Jonathon Reynolds, Vice President of Clinical Operations, Rutland Regional Medical Center
Jeffrey McKee, CEO, Community Health Centers of Burlington
Jessica Barquist, Vice President of Public Affairs, VT, Planned Parenthood of Northern New England
Friday, February 28, 2025
- Committee(s):
- House Committee on Health Care
- 1:00 PM
-
H.266 - An act relating to the 340B prescription drug pricing program
Mark-up
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Tuesday, March 11, 2025
- Committee(s):
- House Committee on Health Care
- 1:00 PM
-
H.266 - An act relating to the 340B prescription drug pricing program
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Jonathan Reynolds, Vice President of Clinical Operations, Rutland Regional Medical Center
Charles Becker, Staff Attorney, Office of the Health Care Advocate, Vermont Legal Aid
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Jeff Hochberg, Director, Rutland Pharmacy
Wednesday, March 12, 2025
- Committee(s):
- House Committee on Health Care
- After Floor
-
H.266 - An act relating to the 340B prescription drug pricing program
Review and Possible Vote
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Wednesday, March 26, 2025
- Committee(s):
- Senate Committee on Health and Welfare
- 9:35 AM
-
H.266 - An act relating to the 340B prescription drug pricing program
Introduction and walk-through
Rep. Daisy Berbeco, Reporter
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Friday, April 4, 2025
- Committee(s):
- Senate Committee on Health and Welfare
- 9:00 AM
-
H.266 - An act relating to the 340B prescription drug pricing program
Testimony
Colleen Meiman, National Policy Advisor, State Associations of Community Health Centers
Mary Kate Mohlman, Director of Public Policy, Bi-State Primary Care Association
Kalvin Pugh, State 340B Policy Director, Community Access National Network
Charles Becker, Staff Attorney, Office of the Health Care Advocate, Vermont Legal Aid
Mike Fisher, Chief Health Care Advocate, Vermont Legal Aid
Thursday, April 10, 2025
- Committee(s):
- Senate Committee on Health and Welfare
- 11:30 AM
-
H.266 - An act relating to the 340B prescription drug pricing program
Morgan Halloran, Director, State Policy, Pharmaceutical Research and Manufacturers of America (PhRMA)
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross Blue Shield of Vermont
Thursday, April 17, 2025
- Committee(s):
- Senate Committee on Health and Welfare
- 11:30 AM
-
H.266 - An act relating to the 340B prescription drug pricing program
Dawn Cogger, 340B Coordinator, Gifford Health Care
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Jeff Hochberg, Director, Rutland Pharmacy
Committee Documents
An act relating to the 340B prescription drug pricing program
Witnesses Who Testified
Regular Session 2025-2026
House Committee on Health Care
- Jessica Barquist, Vice President of Public Affairs, VT, Planned Parenthood of Northern New England
- Charles Becker, Staff Attorney, Office of the Health Care Advocate, Vermont Legal Aid
- Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
- Jordan Estey, V.P. Government Affairs, MVP Health Care
- Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
- Jeff Hochberg, Director, Rutland Pharmacy
- Georgia Maheras, Senior Vice President of Policy and Strategy, Bi-State Primary Care Association
- Jeffrey McKee, CEO, Community Health Centers of Burlington
- Colleen Meiman, National Policy Advisor, State Associations of Community Health Centers
- Jonathan Reynolds, Vice President of Clinical Operations, Rutland Regional Medical Center
- Jonathon Reynolds, Vice President of Clinical Operations, Rutland Regional Medical Center
- Kelly Ryan, Deputy Vice President of State Policy, Pharmaceutical Research and Manufacturers of America (PhRMA)
- Sara Teachout, Director, Government, Public and Media Relations, Blue Cross Blue Shield of Vermont
- Thomas Weigel, Vice President and Chief Medical Officer, Blue Cross Blue Shield of Vermont
Senate Committee on Health and Welfare
- Charles Becker, Staff Attorney, Office of the Health Care Advocate, Vermont Legal Aid
- Rep. Daisy Berbeco, Reporter
- Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
- Dawn Cogger, 340B Coordinator, Gifford Health Care
- Mike Fisher, Chief Health Care Advocate, Vermont Legal Aid
- Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
- Morgan Halloran, Director, State Policy, Pharmaceutical Research and Manufacturers of America (PhRMA)
- Jeff Hochberg, Director, Rutland Pharmacy
- Colleen Meiman, National Policy Advisor, State Associations of Community Health Centers
- Mary Kate Mohlman, Director of Public Policy, Bi-State Primary Care Association
- Kalvin Pugh, State 340B Policy Director, Community Access National Network
- Sara Teachout, Director, Government, Public and Media Relations, Blue Cross Blue Shield of Vermont
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for H.266 in the Regular Session 2025-2026.
No committee of conference members found for H.266 in the Regular Session 2025-2026.
An act relating to the 340B prescription drug pricing program
Committee of Conference Meetings
Regular Session 2025-2026
| Meeting Date | Committee |
|---|
